Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Down 89.4% in August

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) saw a significant drop in short interest during the month of August. As of August 14th, there was short interest totaling 19 shares, a drop of 89.4% from the July 30th total of 180 shares. Based on an average daily trading volume, of 4,928 shares, the days-to-cover ratio is presently 0.0 days.

Carl Zeiss Meditec Stock Down 2.4%

Shares of Carl Zeiss Meditec stock opened at $36.44 on Thursday. Carl Zeiss Meditec has a 1-year low of $26.65 and a 1-year high of $55.94. The business’s fifty day moving average price is $33.62 and its two-hundred day moving average price is $31.33.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Zacks Research lowered shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. UBS Group lowered shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Carl Zeiss Meditec currently has a consensus rating of “Reduce”.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.